Study of PV in Combination With Bendamustine and Rituximab for Patients With R/R MCL
Condition: Lymphoma, Mantle-Cell Interventions: Drug: Polatuzumab vedotin; Drug: Bendamustine Hydrochloride; Drug: Rituximab Sponsor: Czech Lymphoma Study Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2021 Category: Research Source Type: clinical trials
Azacytidine, Bendamustine, Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's Lymphoma
Condition: Non-hodgkin Lymphoma,B Cell Intervention: Drug: Azacytidine, Bendamustine and Piamprizumab Sponsor: Chinese PLA General Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 21, 2021 Category: Research Source Type: clinical trials